Monitor for future closings under this Regulation A offering, as additional tranches could lead to meaningful dilution. Given Dare's small market cap, repeated small financings may signal ongoing funding challenges, which could pressure the stock if larger capital raises follow.
Price Chart
Executive Summary
Dare Bioscience completed a closing of 20,000 Investor Units in a Regulation A offering, with each unit priced at $5.00, consisting of Series A Convertible Preferred Stock and warrants to purchase common stock. The offering raised $100,000 in gross proceeds.
Key Financial Metrics
Key Facts
- Dare Bioscience issued 20,000 Investor Units at $5.00 per unit, raising $100,000 in gross proceeds.
- Each unit consists of one share of Series A Convertible Preferred Stock and two warrants to purchase one share of common stock each, totaling warrants for 40,000 common shares.
- The sale was conducted under a Regulation A offering qualified by the SEC on April 1, 2026.
- Proceeds will be used for general corporate purposes, as typical for early-stage biotech financings.
- The small offering size relative to market cap ($43M) suggests limited immediate financial impact but highlights capital needs.
Financial Impact
$100,000 raised through issuance of 20,000 units at $5.00 each; potential future dilution from 40,000 warrant shares.
Risk Factors
- Future dilution from warrant exercises and potential additional closings under the Regulation A offering.
- Limited proceeds may not significantly extend runway, raising concerns about near-term liquidity and need for further capital raises.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001401914-26-000012 |
| Document: 0001401914-26-000012-index-headers.html | 0001401914-26-000012 |
| Document: 0001401914-26-000012-index.html | 0001401914-26-000012 |
| Document: 0001401914-26-000012.txt | 0001401914-26-000012 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 19d ago | DEF 14A | $0.7900 $0.7720 | ▲ +2.28% | ▲ +1.86% | $0.6467 (+18.14%) |
Oct 1, 2026 25d ago | 8-K | $0.8510 $0.8428 | ▼ −0.96% | ▼ −1.70% | $0.6467 (−24.01%) |
Sep 9, 2026 6w ago | 8-K | $0.7166 $0.7051 | ▼ −1.60% | ▼ −1.01% | $0.6467 (−9.75%) |
Sep 4, 2026 7w ago | EFFECT | $0.7210 $0.7130 | ▲ +1.11% | ▲ +0.56% | $0.6467 (+10.31%) |
Aug 17, 2026 10w ago | 8-K | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 17, 2026 10w ago | 424B5 | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 13, 2026 10w ago | 8-K | $0.9300 $0.8102 | ▼ −12.88% | ▼ −12.41% | $0.6467 (−30.46%) |
Aug 6, 2026 11w ago | Press Release | $1.33 $1.40 | ▲ +5.26% | ▲ +4.65% | $0.6467 (−51.38%) |
Jul 24, 2026 13w ago | 8-K | $1.28 $1.32 | ▲ +3.13% | ▲ +3.10% | $0.6467 (−49.48%) |
Jul 13, 2026 15w ago | 8-K | $2.09 $2.07 | ▼ −0.96% | ▼ −1.31% | $0.6467 (−69.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers